Matches in UGent Biblio for { <https://biblio.ugent.be/publication/2005591#aggregation> ?p ?o. }
Showing items 1 to 40 of
40
with 100 items per page.
- aggregation classification "C3".
- aggregation creator B109977.
- aggregation creator B109978.
- aggregation creator B109979.
- aggregation creator B109980.
- aggregation creator B109981.
- aggregation creator B109982.
- aggregation creator B109983.
- aggregation creator B109984.
- aggregation creator B109985.
- aggregation creator B109986.
- aggregation creator B109987.
- aggregation creator B109988.
- aggregation creator B109989.
- aggregation creator person.
- aggregation date "2011".
- aggregation hasFormat 2005591.bibtex.
- aggregation hasFormat 2005591.csv.
- aggregation hasFormat 2005591.dc.
- aggregation hasFormat 2005591.didl.
- aggregation hasFormat 2005591.doc.
- aggregation hasFormat 2005591.json.
- aggregation hasFormat 2005591.mets.
- aggregation hasFormat 2005591.mods.
- aggregation hasFormat 2005591.rdf.
- aggregation hasFormat 2005591.ris.
- aggregation hasFormat 2005591.txt.
- aggregation hasFormat 2005591.xls.
- aggregation hasFormat 2005591.yaml.
- aggregation isPartOf urn:issn:0923-7534.
- aggregation language "eng".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Time to next anti-lymphoma therapy (TTNT) and treatment-free interval (TFI) with bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed follicular lymphoma (FL)".
- aggregation authorList BK281292.
- aggregation endPage "187".
- aggregation issue "suppl. 4".
- aggregation startPage "187".
- aggregation volume "22".
- aggregation isDescribedBy 2005591.
- aggregation similarTo LU-2005591.